Firm Newsletter, Spring 2008

May 1, 2008

By: Martha S. Helmreich , Michael A. Morse , Kevin E. Raphael , Paul Kenneth Vey

Articles In This Issue:

1. Criminal and Civil Liability to Physicians and Other Health Care Providers For the Off-Label Marketing of FDA-Approved Drugs or Devices: An Emerging Trend?
2. Mandatory Rules For Pennsylvania Medical Facilities For Reporting Medical Errors, Adverse Events And Device Failures
3. Hospital mergers Receive Closer Antitrust  Scrutiny From Federal Trade Commission
4. M-Care Iinfection Control: A Litigation Threat?
5. UPDATE: Federal Pre-emption Of State Tort Claims Involving Medical Devices And Pharmaceutical Products

Related Information:

News & Events

Related News

24 Pietragallo Lawyers Named in 2021 Pennsylvania Super Lawyers and Rising Stars
June 9, 2021
Including Recognition in Top 100 in Pennsylvania and Top 100 In Philadelphia Pietragallo Gordon Alfano Bosick & Raspanti, LLP is pleased to announce that 24 attorneys have been named as 2021 Super Lawyers and 2021 Rising Stars, including two attorneys who were also recognized in the Top 100 in Pennsylvania and Top 100 in Philadelphia. Read More
Chambers USA Recognizes Pietragallo as a Leading Law Firm in Pennsylvania
May 21, 2021
Pietragallo Gordon Alfano Bosick & Raspanti, LLP is pleased to be recognized by Chambers USA in its 2021 guide in the area of Litigation: White-Collar Crime & Government Investigations in Pennsylvania.  Read More

Upcoming Events

Pamela Brecht to present at Seton Hall University School of Law
June 15, 2021
Pamela C. Brecht, Chair of the firm’s Qui Tam & False Claims Act practice, will present “The False Claims Act and Dealing with Whistleblowers” at Seton Hall University School of Law on Tuesday, June 15, 2021. Read More
View More News & Events